What is the primary purpose of the intraocular contact lenses (IPCL) discussed in the article?

The primary purpose of IPCL is to correct myopia and astigmatism by inserting a small lens into the eye.

What material is used in the construction of IPCL, and where else is this material commonly found?

IPCL uses an acrylic polymer material with HEMA as the main component, which is widely used in intraocular lenses for cataracts and contact lenses.

What is a key advantage of IPCL compared to LASIK, according to the article?

A key advantage of IPCL compared to LASIK is that it does not ablate the cornea, making it a highly reversible treatment method.

When did IPCL receive pharmaceutical approval from the Ministry of Health, Labour and Welfare in Japan, and when was it launched?

IPCL received pharmaceutical approval in April 2025 and was launched in September of the same year.

What was the main objective of the awareness survey conducted by At Working Co., Ltd.?

The main objective of the survey was to clarify the awareness and understanding of intraocular contact lenses among men and women aged 20-40 with vision of 0.1 or less.

AI News NQ Analysis

Awareness Survey on Intraocular Contact Lenses (Posterior Chamber Phakic Intraocular Lenses) for Men and Women Aged 20-40 with Vision Below 0.1

NQ Score 56/100

Key facts

Awareness Survey on Intraocular Contact Lenses (Posterior Chamber Phakic Intraocular Lenses) for Men and Women Aged 20-40 with Vision Below 0.1
In April 2025, At Working Co., Ltd. (Headquarters: 5F WORK VILLA MYJ kanda, 1-4 Kanda Ogawacho, Chiyoda-ku, Tokyo), which sells 'IPCL®' (hereinafter referred to as IPCL), approved by the Ministry of Health, Labour and Welfare in April 2025, conducted a survey on intraocular contact lenses targeting men and women aged 20-40 nationwide. IPCL is a treatment method called 'intraocular contact lens' that corrects myopia and astigmatism by inserting a small lens into the eye. It uses an acrylic polyme
Date: Mon Mar 30 2026 06:10:56 GMT+0900 (Japan Standard Time)

Direct answer

In April 2025, At Working Co., Ltd. (Headquarters: 5F WORK VILLA MYJ kanda, 1-4 Kanda Ogawacho, Chiyoda-ku, Tokyo), which sells 'IPCL®' (hereinafter referred to as IPCL), approved by the Ministry of Health, Labour and Welfare in April 2025, conducted a survey on intraocular contact lenses targeting men and women aged 20-40 nationwide. IPCL is a treatment method called 'intraocular contact lens' that corrects myopia and astigmatism by inserting a small lens into the eye. It uses an acrylic polyme

Citation: Awareness Survey on Intraocular Contact Lenses (Posterior Chamber Phakic Intraocular Lenses) for Men and Women Aged 20-40 with Vision Below 0.1 (Mon Mar 30 2026 06:10:56 GMT+0900 (Japan Standard Time)), PR TIMES
Source: PR TIMES
Date: Mon Mar 30 2026 06:10:56 GMT+0900 (Japan Standard Time)

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is the primary purpose of the intraocular contact lenses (IPCL) discussed in the article?: A: The primary purpose of IPCL is to correct myopia and astigmatism by inserting a small lens into the eye.
Q: What material is used in the construction of IPCL, and where else is this material commonly found?: A: IPCL uses an acrylic polymer material with HEMA as the main component, which is widely used in intraocular lenses for cataracts and contact lenses.
Q: What is a key advantage of IPCL compared to LASIK, according to the article?: A: A key advantage of IPCL compared to LASIK is that it does not ablate the cornea, making it a highly reversible treatment method.
Q: When did IPCL receive pharmaceutical approval from the Ministry of Health, Labour and Welfare in Japan, and when was it launched?: A: IPCL received pharmaceutical approval in April 2025 and was launched in September of the same year.
Q: What was the main objective of the awareness survey conducted by At Working Co., Ltd.?: A: The main objective of the survey was to clarify the awareness and understanding of intraocular contact lenses among men and women aged 20-40 with vision of 0.1 or less.